Annual Cash & Cash Equivalents
$93.11 M
+$49.53 M+113.63%
December 1, 2023
Summary
- As of February 12, 2025, CLYM annual cash & cash equivalents is $93.11 million, with the most recent change of +$49.53 million (+113.63%) on December 1, 2023.
- During the last 3 years, CLYM annual cash & cash equivalents has risen by +$72.63 million (+354.49%).
- CLYM annual cash & cash equivalents is now at all-time high.
Performance
CLYM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$146.18 M
-$76.97 M-34.49%
September 1, 2024
Summary
- As of February 12, 2025, CLYM quarterly cash and cash equivalents is $146.18 million, with the most recent change of -$76.97 million (-34.49%) on September 1, 2024.
- Over the past year, CLYM quarterly cash and cash equivalents has dropped by -$76.97 million (-34.49%).
- CLYM quarterly cash and cash equivalents is now -34.49% below its all-time high of $223.14 million, reached on June 1, 2024.
Performance
CLYM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLYM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +113.6% | -34.5% |
| 3 y3 years | +354.5% | -34.5% |
| 5 y5 years | +338.7% | -34.5% |
CLYM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.6% | -34.5% | +477.9% |
| 5 y | 5-year | at high | +354.5% | -34.5% | +613.5% |
| alltime | all time | at high | +354.5% | -34.5% | +613.5% |
Climb Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $146.18 M(-34.5%) |
| Jun 2024 | - | $223.14 M(+112.5%) |
| Mar 2024 | - | $105.03 M(+12.8%) |
| Dec 2023 | $93.11 M(+113.6%) | $93.11 M(+62.3%) |
| Sep 2023 | - | $57.35 M(+126.7%) |
| Jun 2023 | - | $25.29 M(-26.5%) |
| Mar 2023 | - | $34.44 M(-21.0%) |
| Dec 2022 | $43.59 M | $43.59 M(+21.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $35.94 M(+10.3%) |
| Jun 2022 | - | $32.60 M(+2.1%) |
| Mar 2022 | - | $31.93 M(-31.9%) |
| Dec 2021 | $46.92 M(+129.0%) | $46.92 M(-25.3%) |
| Sep 2021 | - | $62.82 M(-36.9%) |
| Jun 2021 | - | $99.48 M(+107.6%) |
| Mar 2021 | - | $47.91 M(+133.9%) |
| Dec 2020 | $20.49 M(-3.5%) | $20.49 M |
| Dec 2019 | $21.22 M | - |
FAQ
- What is Climb Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Climb Bio?
- What is Climb Bio annual cash & cash equivalents year-on-year change?
- What is Climb Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Climb Bio?
- What is Climb Bio quarterly cash and cash equivalents year-on-year change?
What is Climb Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of CLYM is $93.11 M
What is the all time high annual cash & cash equivalents for Climb Bio?
Climb Bio all-time high annual cash & cash equivalents is $93.11 M
What is Climb Bio annual cash & cash equivalents year-on-year change?
Over the past year, CLYM annual cash & cash equivalents has changed by +$49.53 M (+113.63%)
What is Climb Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLYM is $146.18 M
What is the all time high quarterly cash and cash equivalents for Climb Bio?
Climb Bio all-time high quarterly cash and cash equivalents is $223.14 M
What is Climb Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, CLYM quarterly cash and cash equivalents has changed by -$76.97 M (-34.49%)